Increased Risk of Second Hematological and Non-Hematological Malignancies in CLL Patients Treated with Chemotherapy As Compared to Untreated Patients and Matched Controls

Caspar da Cunha-Bang, Klaus Rostgaard, Jacob Simonsen, Christian H. Geisler, Henrik Frederiksen, Henrik Hjalgrim, Kirsten Grønbæk, Carsten Utoft Niemann

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskningpeer review

OriginalsprogEngelsk
Publikationsdato3. dec. 2016
StatusUdgivet - 3. dec. 2016
Begivenhed58th Annual Meeting and Exposition of the American Society of Hematology (ASH) - San Diego, USA
Varighed: 3. dec. 20166. dec. 2016

Konference

Konference58th Annual Meeting and Exposition of the American Society of Hematology (ASH)
LandUSA
BySan Diego
Periode03/12/201606/12/2016

Citationsformater

da Cunha-Bang, C., Rostgaard, K., Simonsen, J., Geisler, C. H., Frederiksen, H., Hjalgrim, H., Grønbæk, K., & Niemann, C. U. (2016). Increased Risk of Second Hematological and Non-Hematological Malignancies in CLL Patients Treated with Chemotherapy As Compared to Untreated Patients and Matched Controls. Abstract fra 58th Annual Meeting and Exposition of the American Society of Hematology (ASH), San Diego, USA.